Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 意见
• 07/14/23
0
0
嵌入
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论